Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Radico Khaitan Q1 Net Profit Rises 70% on Strong Premium Spirits Demand

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Radico Khaitan Q1 Net Profit Rises 70% on Strong Premium Spirits Demand

Analysed 28 Jul 2026·4 sources analysed·Mumbai, India·Business
Radico Khaitan Q1 Net Profit Rises 70% on Strong Premium Spirits DemandPreviousNext

Radico Khaitan reported a consolidated net profit of approximately ₹230 crore for Q1 FY27, marking a 70-76% increase year-on-year. Revenue rose around 10-12% to about ₹5,868 crore, driven by strong demand for premium spirits, which saw volume and revenue growth of over 35%. Expenses increased moderately, while gross margins expanded from 43% to 49.1%. The company highlighted regulatory reforms and a shift to premium brands as key growth factors, with confidence in sustaining margin expansion despite external challenges.

Sentiment
69%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (69/100). Lens Score 34/100.

Outlets measured: businessstandard, businessstandard, freepressjournal. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 28 Jul 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (69/100)

Sentiment was consistent across outlets (62–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

freepressjournal broke this story on 28 Jul, 09:29 am. Other outlets followed.

28 Jul, 09:29 am3 sources · 40 min28 Jul, 10:09 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
India to Source Up to 25% of LPG Imports from US by 2027 to Diversify Supply
Next →
Key Tax Filing Guidelines for Foreign Investments, Real Estate, and REIT Income in India
  1. 1
    freepressjournal28 Jul, 09:29 am
    Radico Khaitan Q1 Consolidated Profit Rises To 229.60 Crore, Revenue At 5,869.46 Crore
  2. 2
    businessstandard28 Jul, 09:42 am
    Radico Khaitan consolidated net profit rises 75.91 in the June 2026 quarter
  3. 3
    businessstandard28 Jul, 10:09 am
    Radico Khaitan gains as Q1 PAT climbs 70 YoY to Rs 226 cr

Who's involved

Institutions and figures named across source coverage.

Corporate
Indoco RemediesIndian Toners DevelopersAmbuja CementsAastha Spintex LtdPfizerRadico Khaitan

Story context

Category
Business
Location
Mumbai, India
Sources analysed
4
Last analysed
28 Jul 2026
Key entities
Radico KhaitanCroreIndian rupeeNet incomeIndiaFiscal yearRevenueAmbuja CementsPfizerExciseKarnatakaSuzlon